Clinical Trials Browser

Phase 2/3 × Withdrawn × Myasthenia Gravis × Clear all

NCT03165435 2018-05-30

A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis

Phase 2/3 Withdrawn

Myasthenia Gravis